In the grand ballroom of the Fairmont San Francisco hotel, overlooking the beautiful skyline, a few people quietly launched the biggest "dementia moonshot" in history.
CareYaya released OpenMind™, curating the world's largest multi-modal neuroscience data set of older adults. 🧠 💪
At America's leading Longevity Conference, the crowd was excited for this unique project that has social impact + enormous scale.
Why?
There's a $1 trillion race by biopharma to find a cure for Alzheimer's and dementia. It's the biggest untapped therapeutics market.
BUT, they sorely lack data.
CareYaya's OpenMind™ is the accelerant that can empower biopharma and bring hope to finding a dementia cure faster. ❤️
How?
Machine learning researchers will leverage OpenMind's largest neurological health dataset for:
- Mining for early biomarkers of cognitive decline
- Identifying novel therapeutic targets for dementia
- Evaluating drug safety and efficacy
CareYaya is proud to launch OpenMind with the TReNDS Center for Translational Research in Neuroimaging and Data Science at Emory, Georgia Tech and Georgia State.
Backed by neurologists at Mass General, Harvard, Penn, Johns Hopkins, Duke and others.
CareYaya's students at Stanford, UC Berkeley and SFSU were happy to demonstrate to the audience how they're rapidly setting up non-invasive EEGs in the field.
By empowering students to rapidly collect neurological health data in the field, we can leverage AI and ML for social impact.
Reach out if you want to collab.
The race to finding a cure just accelerated! 🚀 🌟 ❤️
Mary Furlong AgeTech Collaborative™ from AARP Mel Barsky Centre for Aging + Brain Health Innovation Sarah Tucker Hosna Mohd Zaman Gavry Eshet Nirvana Mansour Hosseini Tari John P. Reinhart Vicky Cattani, Ph.D. Amelia Hay Taryn Thomas Meredith Fenyo